GB0114947D0 - Treatment of DNA Viral Infections in animals - Google Patents

Treatment of DNA Viral Infections in animals

Info

Publication number
GB0114947D0
GB0114947D0 GBGB0114947.5A GB0114947A GB0114947D0 GB 0114947 D0 GB0114947 D0 GB 0114947D0 GB 0114947 A GB0114947 A GB 0114947A GB 0114947 D0 GB0114947 D0 GB 0114947D0
Authority
GB
United Kingdom
Prior art keywords
animals
treatment
viral infections
dna viral
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0114947.5A
Other versions
GB2376628B (en
GB2376628A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henderson Morley Research and Development Ltd
Original Assignee
Henderson Morley Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henderson Morley Research and Development Ltd filed Critical Henderson Morley Research and Development Ltd
Priority to GB0114947A priority Critical patent/GB2376628B/en
Publication of GB0114947D0 publication Critical patent/GB0114947D0/en
Priority to PCT/GB2001/004206 priority patent/WO2002024207A1/en
Priority to AU2001287907A priority patent/AU2001287907A1/en
Priority to EP01967534A priority patent/EP1322316B1/en
Priority to AT01967534T priority patent/ATE435019T1/en
Priority to US10/380,886 priority patent/US20040034016A1/en
Priority to DE60139134T priority patent/DE60139134D1/en
Publication of GB2376628A publication Critical patent/GB2376628A/en
Application granted granted Critical
Publication of GB2376628B publication Critical patent/GB2376628B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0114947A 2000-09-21 2001-06-19 Treatment of DNA viral infections in cats Expired - Fee Related GB2376628B (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB0114947A GB2376628B (en) 2001-06-19 2001-06-19 Treatment of DNA viral infections in cats
PCT/GB2001/004206 WO2002024207A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment
AU2001287907A AU2001287907A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment
EP01967534A EP1322316B1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment
AT01967534T ATE435019T1 (en) 2000-09-21 2001-09-21 DIURETIC OR SULFONYL UREA FOR USE IN ANTIVIRAL TREATMENT
US10/380,886 US20040034016A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment
DE60139134T DE60139134D1 (en) 2000-09-21 2001-09-21 DIETHETICS OR SULFONYL UREA FOR USE IN ANTIVIRAL TREATMENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0114947A GB2376628B (en) 2001-06-19 2001-06-19 Treatment of DNA viral infections in cats

Publications (3)

Publication Number Publication Date
GB0114947D0 true GB0114947D0 (en) 2001-08-08
GB2376628A GB2376628A (en) 2002-12-24
GB2376628B GB2376628B (en) 2005-06-08

Family

ID=9916915

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0114947A Expired - Fee Related GB2376628B (en) 2000-09-21 2001-06-19 Treatment of DNA viral infections in cats

Country Status (1)

Country Link
GB (1) GB2376628B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
GB0616451D0 (en) * 2006-08-18 2006-09-27 Henderson Morley Plc Dna viral infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1242119T3 (en) * 1999-12-30 2004-08-02 Henderson Morley Res & Dev Ltd Combinations for the treatment of DNA viral infections comprising a loop diuretic and a cardiac glycoside

Also Published As

Publication number Publication date
GB2376628B (en) 2005-06-08
GB2376628A (en) 2002-12-24

Similar Documents

Publication Publication Date Title
HUP0400882A3 (en) Oncolytic virus therapy
IL159894A0 (en) Therapeutic agents comprising pro-apoptotic proteins
IL174796A0 (en) Methods for treating viral infection using-il-28 and il-29
GB0329254D0 (en) Treatment of viral infections
IL157251A0 (en) Hepatitis b virus treatment
GB0016920D0 (en) Decondensation of DNA
EP1660116A4 (en) Method of treating viral infections
HK1050011A1 (en) Treatment of viral infections using levovirintm
GB0329958D0 (en) Treatment of viral infections
EP1389972A4 (en) Animal treatment and marking system
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
GB0114947D0 (en) Treatment of DNA Viral Infections in animals
EP1293568A4 (en) Novel protein and dna thereof
EP1322319A4 (en) Use of il-8 protein modulators in the treatment of viral infections
HK1094531A1 (en) P185neu-encoding dna and therapeutical uses thereof
AP2002002432A0 (en) Treatment of viral infections
GB0308603D0 (en) Pharmaceutical combinations for treating viral infections
AU2002327531A1 (en) Therapeutic compositions and methods for treating viral infection
GB0023198D0 (en) Treatment of DNA viral infections
AU2002347346A8 (en) Dna vaccine
GB0023200D0 (en) Synergistic treatment of DNA viral infections
EP1447411A4 (en) Novel protein, its dna and use thereof
GB0128628D0 (en) Disease treatment
EP1428877A4 (en) Novel protein and dna thereof
GB0308604D0 (en) Pharmaceutical combinations for treating viral infections

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120619